BCM
HSTO

BlueCrest Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History

BlueCrest Capital Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-181
Closed -$210K – 1576
2018
Q3 		$210K Sell
181
-305
-63% -$281K 0.01% 1246
2018
Q2 		$416K Buy
+486
New +$404K 0.01% 935

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

BlueCrest Capital Management's HSTO Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q4 2018, closing a stake of 181 shares — an estimated $210K sold.

BlueCrest Capital Management first reported a position in HSTO in Q2 2018 and held it in 2 quarters. The position peaked at $416K in Q2 2018. 52 funds tracked by Wall St. Rank hold HSTO as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Histogen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 181 Histogen Inc. Common Stock shares in Q4 2018, an estimated $210K.
  • BlueCrest Capital Management first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Histogen Inc. Common Stock position peaked at $416K in Q2 2018.
  • 52 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.